Toopi Organics raises €11m from VisVires New Protein, european impact funds, BNP développement and existing investors
Published on :
05/10/2023
05
October
Oct
10
2023
Altaïr Avocats supported lead investor VisVires New Protein in raising €11m for French start-up Toopi Organics alongside European impact funds, BNP Développement and existing investors.
Founded in 2019 by Michael Roes, Toopi Organics is a biotech start-up based in Gironde. Its main expertise lies in the collection and transformation of human urine into microbial biostimulant for use in agriculture.
This financing will enable the company to consolidate its presence in the agricultural market on a European scale and promote its industrial and commercial expansion in France and Belgium.
Altaïr Avocats was involved in the following aspects:
- Corporate & fundraising with a team composed of: Sébastien Péronne (partner), Céline Leparmentier-Delcourt.
- Contract & IP due diligence with a team comprising: Christophe Héry (partner), Albane Watine (associate).
- Tax due diligence with a team comprising: Damien Hautin (partner), Clémence Bauché (associate).
The participants in this operation :
- Toopi Organics was advised by Chammas & Marcheteau (Denis Marcheteau, Romain Penloup, Jeanne Cormerais).
- Investment bank: Avolta (Frédéric Ventre, Christina Fritz, Mehdy Laudrin)
- IP: Aquinov (Julie Cenatiempo)
History
-
Transports Veynat strengthens its territorial deployment with the strategic acquisition of Transports Klein, a gateway to the international market
Published on : 29/02/2024 29 February Feb 02 2024Deals EN
Altaïr Avocats has advised Transports Veynat, the French leader in the transp... -
WE POSITIVE INVEST 2 (ARKEA CAPITAL), WILLE FINANCE and SWEN CAPITAL complete the €8 million fundraising of Beedeez
Published on : 06/02/2024 06 February Feb 02 2024Deals EN
Altaïr Avocats has advised a consortium of investors, WE POSITIVE INVEST 2 (A... -
HEPHAISTOS-Pharma raises €2 million (seed) to accelerate the development of their ONCO-Boost treatment
Published on : 31/01/2024 31 January Jan 01 2024Deals EN
Altaïr Avocats has advised HEPHAISTOS-Pharma, a key player in the biotechnolo... -
Newheat raises €30 million to accelerate its energy transition in Europe
Published on : 28/11/2023 28 November Nov 11 2023Deals EN
Altaïr Avocats supported Newheat in its recent €30 million fundraising. This... -
IRDI Capital Investissement and Banque des Territoires are participating in the €4M financing of the startup Abelio.
Published on : 09/10/2023 09 October Oct 10 2023Deals EN
Altaïr Avocats has advised IRDI Capital Investissement and Banque des Territo... -
QL Clean acquires Bretagne Sud Renovation
Published on : 05/10/2023 05 October Oct 10 2023Deals EN
Altaïr Avocats provided legal counsel to QL Clean in its acquisition of Breta... -
Toopi Organics raises €11m from VisVires New Protein, european impact funds, BNP développement and existing investors
Published on : 05/10/2023 05 October Oct 10 2023Deals EN
Altaïr Avocats supported lead investor VisVires New Protein in raising €11m f...
-
QL Clean acquires the savary group and strengthens its position in the energy solutions market
Published on : 05/10/2023 05 October Oct 10 2023Deals EN
Altaïr Avocats advised the QL Clean investment consortium, led by Jean-Charle... -
BT2i and JV Group: A strategic merger under the guidance of Tikehau capital
Published on : 22/06/2023 22 June Jun 06 2023Deals EN
Altaïr Avocats assisted JV Group and its management in their merger with BT2I...